Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Bioorg Med Chem. 2012 Jul 14;20(17):5181–5187. doi: 10.1016/j.bmc.2012.07.006

Table 1.

Inhibitory constants (nM) for acyclic compounds vs human MTAP and bacterial MTANs

Compound Ki human
MTAPa
nM
Ki E. coli
MTANa
nM
Ki N. men.
MTANa
nM
3 1.0 ± 0.5b,c 0.08 ± 0.02d 0.36e
4 0.09 ± 0.01c 0.002 ± .0002d 0.14e
17 III 12 ± 1 1.7 ± 0.2 0.80 ± .06
17 I 4.4 ± 0.2 0.23 ± 0.2 NDf
17 II 34 ± 3 1.1 ± 0.4 NDf
(±)-25 10 ± 1 0.36 ± 0.04 1.2 ± 0.1
33 5.2 ± 0.4 0.8 ± 0.1 0.9 ± 0.1
ent-33 87 ± 11 3.9 ± 0.5 6 ± 1
40 87 ± 8 10 ± 2 10 ± 1
ent-40 34 ± 18 2.1 ± 0.5 1.8 ± 0.4
47 34 ± 24 5.8 ± 0.8 4 ± 2
54 602 ± 83 40 ± 5 36 ± 4
(±)-65 34 ± 6 9 ± 2 5 ± 1
(±)-68 12 ± 2 2300 ± 600 61 ± 5
(±)-72 105 ± 30 401 ± 37 132 ± 9
(±)-78 368 ± 153 202 ± 35 85 ± 6
79 130 ± 20 1720 ± 850 47 ± 4
a

for compounds 3 and 4 these are Ki* values;

b

Ref 34;

c

Ref 35;

d

Ref 44;

e

Ref 40;

f

ND – not determined